Marcain Spinal (Bupivacaine Hydrochloride)

Marcain Spinal is a long‑acting amide local anesthetic used in regional anesthesia techniques.

• Epidural anesthesia: produces analgesia for labor, cesarean sections, and postoperative pain control.
• Spinal anesthesia: provides rapid, dense block for lower‑body surgeries such as orthopedic or urologic procedures.
• Regional anesthesia for surgical procedures: enables peripheral nerve blocks when combined with other agents for limb surgeries.

• Bupivacaine reversibly binds to voltage‑gated sodium channels on neuronal membranes, stabilising the inactive state of the channel and preventing depolarisation. This inhibition blocks the initiation and propagation of nerve impulses, resulting in loss of sensation and motor function in the targeted region.

Adverse reactions may occur following intrathecal or epidural administration of bupivacaine.

Common Side Effects

• Hypotension: reduced blood pressure due to sympathetic blockade.
• Bradycardia: slowed heart rate, especially with high spinal levels.
• Nausea or vomiting: gastrointestinal upset during onset.
• Urinary retention: temporary inability to void.
• Transient motor weakness: reduced muscle strength in the blocked area.

Serious or Rare Side Effects

• Cardiac toxicity: arrhythmias or cardiac arrest from systemic absorption.
• Central nervous system toxicity: seizures, agitation, or loss of consciousness.
• Respiratory depression: inadequate ventilation due to high block.
• Allergic reactions: rash, itching, or anaphylaxis in sensitised individuals.

Prior to using Marcain Spinal, clinicians should consider several safety measures.

• Assess cardiovascular status: monitor blood pressure and heart rate before and during injection.
• Avoid in patients with known hypersensitivity to amide‑type local anesthetics.
• Use caution in hepatic impairment: reduced metabolism may increase systemic exposure.
• Limit total dose: adhere to recommended maximum to prevent toxicity.
• Pregnancy and breastfeeding: use only when benefit outweighs potential risk and after obstetric consultation.
• Store at below 25°C: keep in the original container, protect from light and moisture.

Bupivacaine may interact with other drugs, altering its safety profile.

Major Interactions (Avoid)

• Other amide local anesthetics: additive neuro‑cardiac toxicity.
• Class I antiarrhythmics (e.g., quinidine, procainamide): increased risk of cardiac conduction disturbances.
• Beta‑blockers: may potentiate bradycardia and hypotension.

Moderate Interactions (Monitor Closely)

• CYP3A4 inhibitors (e.g., ketoconazole, erythromycin): may raise plasma concentrations.
• Alpha‑2 agonists used adjunctively (e.g., clonidine): can enhance hypotensive effects.
• Diuretics: may affect plasma protein binding and increase free drug levels.